-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $4

Benzinga·05/11/2026 18:24:54
Listen to the news
TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the price target from $3 to $4.